Clinical Trials in New York

Showing 10501-10520 of 22,668 trials

Attitudes Toward Food During a Weight Loss Intervention

NCT04586647

The purpose of this study is to evaluate whether the Noom Healthy Weight Program, a digital behavior change weight loss intervention, creates a positive relationship with food, compared to a waitlist control group.

ObesityWeight LossOverweight and Obesity+4 more

Noom Inc.160 participantsStarted Nov 2020

New York, New York, United States

UNKNOWNNA< 1 mile

High Intensity Interval Gait Training in Multiple Sclerosis

NCT05560880

Over 90% of persons with MS (pwMS) complain of difficulty with walking. High intensity interval gait training (HIIGT), where persons alternate brief periods of walking at high speeds with periods of rest has been found to improve walking in other neurologic diagnoses. However its impact on pwMS is not known. Most gait training in MS is done continuously at a slower pace. The purpose of this study is to compare the effects of HIIGT to traditional Moderate Intensity Continuous Gait Training (MICGT) in pwMS.

Multiple Sclerosis

Hunter College of City University of New York30 participantsStarted Sep 2022

New York, New York, United States

COMPLETEDPhase 3< 1 mile

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

NCT03465722

This is an open-label, randomized, Phase 3 study in patients with locally advanced unresectable or metastatic GIST (advanced GIST) of avapritinib (also known as BLU-285) versus regorafenib in patients previously treated with imatinib and 1 or 2 other TKIs.

GIST

Blueprint Medicines Corporation476 participantsStarted Mar 2018

Phoenix, Arizona, United States • Santa Monica, California, United States • Aurora, Colorado, United States +111 more locations

Attitudes Toward Food During a Weight Loss Intervention

High Intensity Interval Gait Training in Multiple Sclerosis

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Find Trials by Condition in New York

Online Emotion Regulation Group Intervention

FILtration of Subarachnoid Hemorrhage Via SpinaL CAtheteR Extension

Trial of Roflumilast in Asthma Management (TRIM)

Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Defense Health Agency- Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

Telehealth After Stroke Care: Integrated Multidisciplinary Access to Post-stroke Care

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD

The Role of Resistant Starch in COVID-19 Infection

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)